Pro Pharmaceuticals intends to set up a subsidiary in the Shanghai Free Trade Zone to provide CDMO research and development and production services to domestic and foreign customers.

Introduction: Pro Pharmaceuticals intends to invest in the establishment of Shanghai Prodrive Pharmaceutical Technology Co., Ltd.
. Pro Pharmaceutical Co., Ltd. in order to achieve the "stronger CDMO" strategy, make full use of the Shanghai Free Trade Zone policy advantages, regional advantages and talent highland advantages, the company intends to invest in the Shanghai Free Trade Zone to set up Shanghai ProTronZhi Pharmaceutical Technology Co., Ltd. (tentative name, with business approval as the basis), so that the company can better connect with large domestic and foreign pharmaceutical enterprises, and provide domestic and foreign customers with more efficient and high-quality CDMO research and development and production services.
capital contribution: the company with its own capital to contribute 15 million yuan, that is, the company holds a 100% stake in Shanghai Protronzhi Pharmaceutical Technology Co., Ltd.
Business scope: Technology development, technology transfer, technical advice, technical services, chemical products (except hazardous chemicals, monitoring chemicals, fireworks, civil explosives, toxic chemicals) sales, engaged in the import and export of goods and technology business.
(which is based on business approval).
.